Meet Justin Jee: Thoracic Medical Oncologist at MSK

Dr. Justin Jee treats lung cancers at MSK, including non-small cell (NSCLC) and small cell (SCLC), offering targeted therapies and clinical trials for personalized care.
Video Details
 Justin Jee

Justin Jee, MD, PhD

Thoracic Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Lung cancer
  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)

My Specialties

  • Immunotherapy
  • Targeted therapy
  • Clinical trials
Dr. Jee's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

As a thoracic medical oncologist, my goal is to bring hope to my patients with lung cancer and provide them with the best treatment options possible. I work with a world-class interdisciplinary team to deliver the best care to patients during an especially vulnerable time.

I also study how biomedical data can improve cancer therapy effectiveness and minimize side effects. I lead MSK’s Clinical Data Mining Team, which includes a group of engineers, data scientists, graduate students, and postdoctoral fellows. 

Together, we work to harness artificial intelligence to predict how patients will respond to cancer treatments and discover ways to improve their quality and length of life. We have led large, multi-center and international studies of how tumor genomics affect patient outcomes and ways that new technologies such as liquid biopsies might improve cancer care. 

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

  • Instructor
Areas of Expertise

Conditions I Treat

  • Lung cancer
  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)

My Specialties

  • Immunotherapy
  • Targeted therapy
  • Clinical trials
Education & Honors

Education

  • MD New York University
  • PhD New York University

Residencies

  • Internal Medicine, New York Presbyterian/Columbia

Fellowships

  • Medical Oncology, Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Awards and Honors

  • The National Cancer Institute (NCI) Mentored Clinical Scientist Research Career Development Award (K08)
  • K12 Paul Calabresi Career Development Award for Clinical Oncology, NIH/MSK (2023-2026)
  • Young Investigator Award, ASCO Conquer Cancer Foundation (2023)
  • Merit Award, ASCO Conquer Cancer Foundation (2021, 2023)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9163— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Location
New York, NY
Memorial Sloan Kettering Cancer Center
1275 York Avenue New York NY 10065
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Thoracic Oncology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Jee, J., Fong, C., Pichotta, K. et al. Automated real-world data integration improves cancer outcome prediction. Nature (2024). 

Jee J, Tang, C., Castillon, V.J., Waters, M. et al. Obesity-dependent selection of driver mutations in cancer. Nat Genet 56, 2318–2321 (2024). 

Jee, J., Brannon, A.R., Singh, R. et al. DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism. Nat Med 30, 2499–2507 (2024). 

Jee J, Lebow ES, Yeh R, Das JP, Namakydoust A, Paik PK, Chaft JE, Jayakumaran G, Rose Brannon A, Benayed R, Zehir A, Donoghue M, Schultz N, Chakravarty D, Kundra R, Madupuri R, Murciano-Goroff YR, Tu HY, Xu CR, Martinez A, Wilhelm C, Galle J, Daly B, Yu HA, Offin M, Hellmann MD, Lito P, Arbour KC, Zauderer MG, Kris MG, Ng KK, Eng J, Preeshagul I, Victoria Lai W, Fiore JJ, Iqbal A, Molena D, Rocco G, Park BJ, Lim LP, Li M, Tong-Li C, De Silva M, Chan DL, Diakos CI, Itchins M, Clarke S, Pavlakis N, Lee A, Rekhtman N, Chang J, Travis WD, Riely GJ, Solit DB, Gonen M, Rusch VW, Rimner A, Gomez D, Drilon A, Scher HI, Shah SP, Berger MF, Arcila ME, Ladanyi M, Levine RL, Shen R, Razavi P, Reis-Filho JS, Jones DR, Rudin CM, Isbell JM, Li BT. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. Nat Med. 2022 Nov;28(11):2353-2363. doi: 10.1038/s41591-022-02047-z. Epub 2022 Nov 10. PMID: 36357680.

Jee, J.*; Foote, M.*; Lumish, M.*; Stonestrom, A.J.*; Wills, B.*; Narendra, V.*; Avutu, V.; Murciano-Goroff, Y.R.; Chan, J.E.; Derkach, A.; Philip, J.; Belenkaya, R.; Kerpelev, M.; Maloy, M.; Watson, A.; Fong, C.; Janjigian, Y.; Diaz Jr., L.A.; Bolton, K.; Pessin, M. Chemotherapy and Covid-19 outcomes in cancer patients. Journal of Clinical Oncology. 2020 doi:10.1200/JCO.20.01307

Jee, J.; Rasouly, A.; Shamovsky, I.; Akivis, Y.; Steinman, S.; Mishra, B.*; Nudler, E*. Rates and Mechanisms of Bacterial Mutagenesis from Maximum-Depth Sequencing. Nature. 2016. doi: 10.1038/nature18313

Publications on PubMed

Visit PubMed for a full listing of Dr. Jee’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Justin Jee discloses the following relationships and financial interests:

  • MDSeq Inc
    Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: